Beneficial Effect of Statin Therapy on Arterial Stiffness

Arterial stiffness describes the increased rigidity of the arterial wall that occurs as a consequence of biological aging and several diseases. Numerous studies have demonstrated that parameters to assess arterial stiffness, especially pulse-wave velocity, are predictive of those individuals that will suffer cardiovascular morbidity and mortality. Statin therapy may be a pharmacological strategy to improve arterial elasticity. It has been shown that the positive benefits of statin therapy on cardiovascular disease is attributable not only to their lipid-lowering capacity but also to various pleiotropic effects, such as their anti-inflammatory, antiproliferative, antioxidant, and antithrombotic properties. Additionally, statins reduce endothelial dysfunction, improve vascular and myocardial remodeling, and stabilize atherosclerotic plaque. The aim of the present review was to summarize the evidence from human studies showing the effects of statins on arterial stiffness.

[1]  A. Sahebkar,et al.  Effects of statins on brain tumors: a review. , 2020, Seminars in cancer biology.

[2]  M. Banach,et al.  The potential role of plant-derived natural products in improving arterial stiffness: A review of dietary intervention studies , 2020 .

[3]  T. Sathyapalan,et al.  The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review , 2020, Current Atherosclerosis Reports.

[4]  T. Sathyapalan,et al.  The effects of statins on microglial cells to protect against neurodegenerative disorders: A mechanistic review , 2019, BioFactors.

[5]  M. Banach,et al.  Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications , 2019, Journal of clinical medicine.

[6]  S. Asthana,et al.  Effects of Simvastatin on Augmentation Index Are Transient: Outcomes From a Randomized Controlled Trial , 2019, Journal of the American Heart Association.

[7]  I. Mozoș,et al.  Links between High-Sensitivity C-Reactive Protein and Pulse Wave Analysis in Middle-Aged Patients with Hypertension and High Normal Blood Pressure , 2019, Disease markers.

[8]  M. Climent,et al.  DIFFERENCES IN AORTIC AUGMENTATION PRESSURE BETWEEN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS MEASURED IN COMMUNITY PHARMACIES IN SPAIN , 2019, Journal of Hypertension.

[9]  Hong Yuan,et al.  Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population , 2019, Hypertension Research.

[10]  N. Benkirane-Jessel,et al.  Contribution of Statins towards Periodontal Treatment: A Review , 2019, Mediators of inflammation.

[11]  M. Budoff,et al.  Cardio‐ankle vascular index and cardiovascular disease: Systematic review and meta‐analysis of prospective and cross‐sectional studies , 2018, Journal of clinical hypertension.

[12]  Y. Yoon,et al.  Assessing Impact of High-Dose Pitavastatin on Carotid Artery Elasticity with Speckle-Tracking Strain Imaging , 2018, Journal of atherosclerosis and thrombosis.

[13]  C. Vlachopoulos,et al.  Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia , 2018, Diabetes & vascular disease research.

[14]  L. D’elia,et al.  Effect of statin therapy on pulse wave velocity: A meta-analysis of randomized controlled trials , 2018, Clinical and experimental hypertension.

[15]  F. Montecucco,et al.  Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia. , 2017, International journal of cardiology.

[16]  Z. Fras,et al.  Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot study , 2017, Archives of medical science : AMS.

[17]  T. Delhaas,et al.  Arterial stiffness index beta and cardio-ankle vascular index inherently depend on blood pressure but can be readily corrected , 2016, Journal of hypertension.

[18]  C. Jimenez-Ortiz,et al.  Short-term atorvastatin therapy improves arterial stiffness of middle-aged systemic lupus erythematosus patients with pathological pulse wave velocity , 2017, Lupus.

[19]  Guo-Yuan Yang,et al.  Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke , 2017, Stroke and Vascular Neurology.

[20]  H. Yip,et al.  The therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced rabbit aortic atherosclerosis and stiffness. , 2017, International journal of cardiology.

[21]  S. Upala,et al.  Effects of statin therapy on arterial stiffness: A systematic review and meta-analysis of randomized controlled trial. , 2017, International journal of cardiology.

[22]  Д. А. Васильева,et al.  ГИПОЛИПИДЕМИЧЕСКАЯ И ПЛЕЙОТРОПНАЯ ЭФФЕКТИВНОСТЬ РОЗУВАСТАТИНА У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ С ВЫСОКИМ СЕРДЕЧНО-СОСУДИСТЫМ РИСКОМ В УСЛОВИЯХ ДЛИТЕЛЬНОГО АМБУЛАТОРНОГО НАБЛЮДЕНИЯ , 2016 .

[23]  A. Deep,et al.  Pleiotropic effects of statins: A boulevard to cardioprotection , 2016 .

[24]  E. Papadimitriou,et al.  Inhibition of Atherosclerosis Progression, Intimal Hyperplasia, and Oxidative Stress by Simvastatin and Ivabradine May Reduce Thoracic Aorta’s Stiffness in Hypercholesterolemic Rabbits , 2016, Journal of cardiovascular pharmacology and therapeutics.

[25]  A. Sahebkar,et al.  Effects of statin therapy on augmentation index as a measure of arterial stiffness: A systematic review and meta-analysis. , 2016, International journal of cardiology.

[26]  Puneet Kumar,et al.  Pleiotropic effects of statins: new therapeutic targets in drug design , 2016, Naunyn-Schmiedeberg's Archives of Pharmacology.

[27]  Inge Christoffer Olsen,et al.  Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study , 2016, PloS one.

[28]  J. L. Valera,et al.  Effects of simvastatin in chronic obstructive pulmonary disease: Results of a pilot, randomized, placebo-controlled clinical trial , 2016, Contemporary clinical trials communications.

[29]  A. Sahebkar,et al.  The impact of statin therapy on plasma levels of von Willebrand factor antigen , 2015, Thrombosis and Haemostasis.

[30]  Inge Christoffer Olsen,et al.  Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study , 2015, Arthritis Research & Therapy.

[31]  M. Banach,et al.  Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials. , 2015, Atherosclerosis.

[32]  P. Thompson,et al.  Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia , 2015, Advances in preventive medicine.

[33]  D. O'Gorman,et al.  The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes , 2015, Journal of diabetes research.

[34]  J. Cockcroft,et al.  Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial , 2015, International journal of chronic obstructive pulmonary disease.

[35]  N. Tanahashi,et al.  Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[36]  J. Pépin,et al.  Response to Statin Therapy in Obstructive Sleep Apnea Syndrome: A Multicenter Randomized Controlled Trial , 2014, Mediators of inflammation.

[37]  Yingping Liu,et al.  [Effects of rosuvastatin on arterial stiffness in hyperlipidemia patients]. , 2014, Zhonghua yi xue za zhi.

[38]  T. Coutinho Arterial stiffness and its clinical implications in women. , 2014, The Canadian journal of cardiology.

[39]  B. Oh,et al.  Gender Difference in Arterial Stiffness in a Multicenter Cross-Sectional Study: The Korean Arterial Aging Study (KAAS) , 2014, Pulse.

[40]  Z. Du,et al.  Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease , 2014, World journal of pediatrics : WJP.

[41]  A. Cansu,et al.  Augmentation index and aortic pulse wave velocity in patients with abdominal aortic aneurysms. , 2014, International journal of clinical and experimental medicine.

[42]  G. Szücs,et al.  Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis - a prospective case-series study , 2013, Arthritis Research & Therapy.

[43]  I. Young,et al.  Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[44]  Hyuk-Jae Chang,et al.  Impact of Atorvastatin Treatment in First‐Degree Relatives of Patients With Premature Coronary Artery Disease With Endothelial Dysfunction: A Double‐Blind, Randomized, Placebo‐Controlled Crossover Trial , 2013, Clinical cardiology.

[45]  P. Sarafidis,et al.  Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia. , 2013, American journal of hypertension.

[46]  A. Papavassiliou,et al.  Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure. , 2013, Atherosclerosis.

[47]  Bradley S. Fleenor Large elastic artery stiffness with aging: novel translational mechanisms and interventions. , 2013, Aging and disease.

[48]  K. Kohara,et al.  Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia , 2012, Menopause.

[49]  C. Vlachopoulos,et al.  Prediction of Cardiovascular Events and All-Cause Mortality With Brachial-Ankle Elasticity Index: A Systematic Review and Meta-Analysis , 2012, Hypertension.

[50]  F. Ohsuzu,et al.  Statin inhibits hypoxia-induced endothelin-1 via accelerated degradation of HIF-1α in vascular smooth muscle cells. , 2012, Cardiovascular research.

[51]  P. Chowienczyk,et al.  Role of arterial stiffness in cardiovascular disease , 2012, JRSM cardiovascular disease.

[52]  R. Schmieder,et al.  Rosuvastatin improves pulse wave reflection by restoring endothelial function. , 2012, Microvascular research.

[53]  E. Tireli,et al.  Single high dose atorvastatin does not ameliorate endothelial function and large arterial stiffness in dyslipidemic patients without atherosclerosis. , 2012, European review for medical and pharmacological sciences.

[54]  Zhijian Yang,et al.  Improvement of Arterial Stiffness by Reducing Oxidative Stress Damage in Elderly Hypertensive Patients After 6 Months of Atorvastatin Therapy , 2012, Journal of clinical hypertension.

[55]  R. Sacco,et al.  Short-Term Effect of Atorvastatin on Carotid Artery Elasticity: A Pilot Study , 2011, Stroke.

[56]  B. Tomlinson,et al.  Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial , 2011, Scandinavian journal of rheumatology.

[57]  Y. Yazaki,et al.  Low-dose rosuvastatin improves arterial stiffness in high-risk Japanese patients with dyslipdemia in a primary prevention group. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[58]  M. Lunder,et al.  Subtherapeutic, low-dose fluvastatin improves functional and morphological arterial wall properties in apparently healthy, middle-aged males--a pilot study. , 2011, Atherosclerosis.

[59]  Joseph Cheriyan,et al.  Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction. , 2010, British journal of clinical pharmacology.

[60]  Hae-Young Lee,et al.  Aging and arterial stiffness. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[61]  M. Zou,et al.  Arterial stiffness: a brief review , 2010, Acta Pharmacologica Sinica.

[62]  Yasmin,et al.  Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’ , 2010, European heart journal.

[63]  J. Sharman,et al.  Effects of atorvastatin on arterial stiffness in chronic kidney disease: a randomised controlled trial. , 2010, Journal of atherosclerosis and thrombosis.

[64]  Michael J. Pencina,et al.  Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study , 2010, Circulation.

[65]  Xiao Meng,et al.  Assessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocity. , 2009, Clinical and investigative medicine. Medecine clinique et experimentale.

[66]  A. Saiki,et al.  Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients. , 2009, Journal of atherosclerosis and thrombosis.

[67]  J. Orr,et al.  Arterial Destiffening With Atorvastatin in Overweight and Obese Middle-Aged and Older Adults , 2009, Hypertension.

[68]  J. Egido,et al.  Atorvastatin Prevents Angiotensin II–Induced Vascular Remodeling and Oxidative Stress , 2009, Hypertension.

[69]  J. D. H. Miralles,et al.  In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[70]  J. Cohn,et al.  Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia. , 2009, American journal of hypertension.

[71]  S. Chowdhury,et al.  Atorvastatin improves arterial stiffness in normotensive normolipidaemic persons with type 2 diabetes. , 2008, Journal of the Indian Medical Association.

[72]  Y. Yılmaz,et al.  Effect of intensive statin therapy on arterial elasticity in patients with coronary artery disease , 2008, Acta cardiologica.

[73]  M. Cooper,et al.  The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation , 2008, Diabetologia.

[74]  Y. Yazaki,et al.  Fluvastatin improves arterial stiffness in patients with coronary artery disease and hyperlipidemia: a 5-year follow-up study. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[75]  K. Kim,et al.  The Short-term Effect of Atorvastatin on Flow-Mediated Vasodilation, Pulse Wave Velocity and Carotid Intima-Media Thickness in Patients With Moderate Cholesterolemia , 2008 .

[76]  C. D. A. Stehouwer,et al.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease , 2008, Diabetologia.

[77]  E. Kim,et al.  Impact of aortic stiffness on cardiovascular disease in patients with chest pain: assessment with direct intra-arterial measurement. , 2007, American journal of hypertension.

[78]  I. Wilkinson,et al.  Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. , 2007, Journal of the American College of Cardiology.

[79]  R. Paltriccia,et al.  Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[80]  C. Stefanadis,et al.  Beneficial effects of statins on endothelial dysfunction and vascular stiffness. , 2007, Current vascular pharmacology.

[81]  S. Efrati,et al.  The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers , 2007, European Journal of Clinical Pharmacology.

[82]  Y. Aizawa,et al.  The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia. , 2006, Journal of atherosclerosis and thrombosis.

[83]  P. Hordijk Regulation of NADPH Oxidases: The Role of Rac Proteins , 2006, Circulation research.

[84]  M. Kawasaki,et al.  Effects of fluvastatin on the carotid arterial media as assessed by integrated backscatter ultrasound compared with pulse-wave velocity. , 2005, Journal of the American College of Cardiology.

[85]  E. Lakatta,et al.  Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults , 2005, Circulation.

[86]  D. Kass,et al.  Mechanisms, pathophysiology, and therapy of arterial stiffness. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[87]  Hideya Yamamoto,et al.  Pulse Wave Velocity Predicts Cardiovascular Mortality , 2005 .

[88]  T. Saruta,et al.  Long-term effects of statins on arterial pressure and stiffness of hypertensives , 2005, Journal of Human Hypertension.

[89]  G. McColl,et al.  Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis , 2004, Annals of the rheumatic diseases.

[90]  J. Liao,et al.  Inhibition of Rho-Kinase Leads to Rapid Activation of Phosphatidylinositol 3-Kinase/Protein Kinase Akt and Cardiovascular Protection , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[91]  H. Robenek,et al.  Differential modulation of caveolin-1 expression in cells of the vasculature by statins. , 2004, Circulation.

[92]  S. Vehid,et al.  Effects of low and high doses of atorvastatin on arterial compliance. , 2003, Japanese heart journal.

[93]  K. Sutton-Tyrrell,et al.  Measures of Obesity Are Associated With Vascular Stiffness in Young and Older Adults , 2003, Hypertension.

[94]  R. Zimlichman,,et al.  Treatment with amlodipine and atorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients. , 2003, American journal of hypertension.

[95]  H. Boudoulas,et al.  Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients , 2003, Current medical research and opinion.

[96]  S. Anderson,et al.  Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance: An Integrated Index of Vascular Function? , 2002, Circulation.

[97]  M. Safar,et al.  Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study , 2002, Journal of Human Hypertension.

[98]  T. Saruta,et al.  Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[99]  R. Zimlichman,,et al.  Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia. , 2001, American journal of hypertension.

[100]  U. Laufs,et al.  HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen Species , 2001, Hypertension.

[101]  P. Ducimetiere,et al.  Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients , 2001, Hypertension.

[102]  A. Dart,et al.  Simvastatin improves arterial compliance in the lower limb but not in the aorta. , 2001, Atherosclerosis.

[103]  P. Libby,et al.  An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro , 2001, Circulation.

[104]  C. Dessy,et al.  Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance , 2001, Circulation.

[105]  U. Laufs,et al.  Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment Is Mediated by Negative Feedback Regulation of Rho GTPase Gene Transcription , 2000, Circulation.

[106]  J. Farmer Pleiotropic effects of statins , 2000, Current atherosclerosis reports.

[107]  H. Katus,et al.  Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. , 2000, Circulation.

[108]  G. Nickenig,et al.  Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. , 1999, Circulation.

[109]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[110]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[111]  J. Blacher,et al.  Impact of aortic stiffness on survival in end-stage renal disease. , 1999, Circulation.

[112]  J. Balligand,et al.  Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. , 1999, The Journal of clinical investigation.

[113]  U. Laufs,et al.  Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase* , 1998, The Journal of Biological Chemistry.

[114]  J. Navarro-Antolín,et al.  Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. , 1998, The Journal of clinical investigation.

[115]  R. Naoumova,et al.  The Effect of Cholesterol Reduction with Fluvastatin on Aortic Compliance, Coronary Calcification and Carotid Intimal-Medial Thickness: A Pilot Study , 1998, Journal of cardiovascular risk.

[116]  C. Wiedermann,et al.  Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin. , 1997, Circulation research.

[117]  J. Muramatsu,et al.  Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin. , 1997, Atherosclerosis.

[118]  M. Doumas,et al.  Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension. , 2018, Current vascular pharmacology.

[119]  M. Pase Dietary approaches to reduce aortic stiffness , 2016 .

[120]  C. Ersoy,et al.  Does Fluvastatin Improve Arterial Functions in Dyslipidemic RenalTransplant Recipients , 2014 .

[121]  Z. Du,et al.  Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease , 2014, World Journal of Pediatrics.

[122]  W. Che,et al.  Effects of rosuvastatin vs. simvastatin/ezetimibe on arterial wall stiffness in patients with coronary artery disease. , 2013, Internal medicine.

[123]  пульсовой волны Rosuvastatin in patients with arterial hypertension and dyslipidemia: effects on microcirculation and pulse wave parameters , 2012 .

[124]  I. Wilkinson,et al.  Anti-inflammatory drugs and statins for arterial stiffness reduction. , 2009, Current pharmaceutical design.

[125]  J. Mehta,et al.  Modulation of atherosclerosis, blood pressure and arterial elasticity by statins. , 2007, Advances in cardiology.

[126]  B. Tesfamariam The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function , 2006, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[127]  M. Horie,et al.  Effect of Statin Therapy on Arterial Stiffness in Patients with Hyperlipidemia:Shiga Pravastatin Atherosclerosis Study (SHIPAS) Group , 2005 .

[128]  A. Babkin,et al.  [Changes of elastic properties of magistral arteries in patients with ischemic heart disease during treatment with atorvastatin and simvastatin]. , 2005, Kardiologiia.

[129]  S. Fukumoto,et al.  Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus. , 2005, Journal of atherosclerosis and thrombosis.